Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0546837 (
esophageal cancer
)
8,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MicroRNAs (miRNAs) act as key regulators of multiple cancers. MicroRNA-506 (miR-506) functions as a tumor suppressor in various types of cancers. However, its role in
esophageal cancer
remains unclear. In our study, we found that miR-506 was significantly down-regulated in
esophageal cancer
tissues and cell lines. In vitro assay, our results showed that ectopic over-expression of miR-506 inhibited
esophageal cancer
cells proliferation, meanwhile, cells proliferation was promoted by miR-506 inhibition. In exploring mechanisms underlying the inhibitive role, we found that miR-506 significantly decreased the expression and transcription activity of
cAMP responsive element binding protein 1
(
CREB1
).
CREB1
, tumor oncogene, exhibited significantly promote effect on
esophageal cancer
cell proliferation. Taken together, our data identify a new role of miR-506 in
esophageal cancer
involving
CREB1
suppression.
...
PMID:MicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1. 2661 1